Cause-specific mortality associated with leukoreduced, buffy coat-depleted, or no blood transfusion after elective surgery for colorectal cancer: A posttrial 15-year follow-up study

Transfusion

Volumn 51, Issue 2, 2011, Pages 259-263

  Mortensen, Frank V ^a   Jensen, Lone S ^a   Sørensen, Henrik T ^a   Pedersen, Lars ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD BUFFY COAT; BLOOD TRANSFUSION; BUFFY COAT DEPLETED BLOOD TRANSFUSION; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COLORECTAL CANCER; COLORECTAL DISEASE; COMORBIDITY; DEATH CERTIFICATE; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; LEUKOREDUCED BLOOD TRANSFUSION; MAJOR CLINICAL STUDY; MALE; RECTUM CANCER; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COLONIC NEOPLASMS; COMORBIDITY; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSION; INTERNATIONAL CLASSIFICATION OF DISEASES; LEUKOCYTE REDUCTION PROCEDURES; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASMS, SECOND PRIMARY; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; SURGICAL PROCEDURES, ELECTIVE;

EID: 79951601850     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02825.x     Document Type: Article

References (14)

1. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N,. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841-5. (Pubitemid 26320898)
2. Jensen LS, Puho E, Pedersen L, Mortensen FV, SÃrensen HT,. Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow up study. Lancet 2005; 365: 681-82. (Pubitemid 40260890)
3. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeckel J,. Blood transfusion and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-6. (Pubitemid 23131389)
4. Houbiers JGA, Brand A, van de Watering LM,. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573-8. (Pubitemid 24267215)
5. Tartter P,. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992; 216: 633-8.
6. Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka KW, Mempel M, Dieterich HJ, Eissner HJ, Schildberg FW,. Blood transfusion-modulated tumour recurrence: first results of a randomized study of autologous versus allogenic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-67. (Pubitemid 24349388)
7. Klein HG,. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 1999; 91: 861-5. (Pubitemid 29418669)
8. Blajchman MA,. Immunomodulation and blood transfusion. Am J Ther 2002; 9: 389-95.
9. Duke's CE,. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323-32.
10. Juel K, Helweg-Larsen K,. The Danish registers of causes of death. Dan Med Bull 1999; 46: 354-7. (Pubitemid 29439149)
11. Opelz G, Sengar DP, Mickey MR, Terasaki PI,. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253-9.
12. Hansson GK,. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
13. Koch CG, Li L, Duncan IA, Mihaljevic T, Loop FD, Starr NJ, Blackstone HE,. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81: 1650-7. (Pubitemid 350030027)
14. Kamper-JÃrgensen M, Ahlgren M, Rostgaard K, Melbye M, Edgren G, Nyren O, Reily M, Norda R, Titlestad K, Tynell E, Hjalgrim H,. Survival after blood transfusion. Transfusion 2008; 48: 2577-84.